BridgeMD
Tests treatment safety and results for Recurrent Acute Pancreatitis
Official title Efficacy of ERCP in the Diagnosis and Treatment of Idiopathic Recurrent Acute Pancreatitis
ClinicalTrials.gov ID: NCT06364397
What this study is testing
What is Health education and conservative management of clinical routines?
Health education and conservative management of clinical routines is an investigational medicine, being studied as a potential treatment for recurrent acute pancreatitis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if endoscopic retrograde cholangiopancreatography (ERCP) works to treat idiopathic recurrent pancreatitis (IRAP) in adults. It also clarify the efficacy of ERCP in the diagnosis of IRAP.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Aged 18 to 70 years.
- Patients diagnosed with IRAP:
- Previously experienced 2 or more distinct episodes of acute pancreatitis (AP) with complete resolution between each episode, and absence of...
- The etiology of RAP remains undetermined after routine clinical investigations, including history, laboratory examination, imaging examination (CT...
- At least 1 episode of AP one year prior to enrollment.
You likely can't join if
- Prior sphincter intervention.
- Not recovered from prior AP attack.
- Prior pancreatic surgery.
- Contraindications to ERCP.
- Major mental illness or serious health problems that are not suitable for participation in the study.
- Pregnancy or plan for pregnancy within 12 months of enrollment.
See the full eligibility criteria
- Aged 18 to 70 years.
- Patients diagnosed with IRAP:
- Previously experienced 2 or more distinct episodes of acute pancreatitis (AP) with complete resolution between each episode, and absence of irreversible structural and functional changes in pancreas. The diagnosis of AP...
- The etiology of RAP remains undetermined after routine clinical investigations, including history, laboratory examination, imaging examination (CT, MRI/MRCP, EUS). Patients who still have AP episodes after elimination...
- At least 1 episode of AP one year prior to enrollment.
- Consent to participate in the study and sign the informed consent form.
- Prior sphincter intervention.
- Not recovered from prior AP attack.
- Prior pancreatic surgery.
- Contraindications to ERCP.
- Major mental illness or serious health problems that are not suitable for participation in the study.
- Pregnancy or plan for pregnancy within 12 months of enrollment.
- Other conditions that inappropriate to participant in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.